Wilson disease as a cause of liver injury in cystic fibrosis

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients  Thomas.
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery.
A wide methodological approach to identify a large duplication in CFTR gene in a CF patient uncharacterised by sequencing analysis  Lucy Costantino, Damiana.
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Splicing defects in the CFTR gene: Minigene analysis of two mutations, G>C and A>G  Gwendal Dujardin, Diane Commandeur, Catherine Le Jossic-Corcos,
A 10-year large-scale cystic fibrosis carrier screening in the Italian population  Luigi Picci, Marilena Cameran, Oriana Marangon, Diana Marzenta, Stefano.
Cystic fibrosis: A new mutation in the Lebanese population
K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients  Thomas.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Samantha A. Woodruff, Marci K. Sontag, Frank J. Accurso, Ronald J
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry.
Cirrhosis and other liver disease in cystic fibrosis
Controlled clinical trials in cystic fibrosis — are we doing better?
Characterization of a recurrent 3
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c G>A  Aleksandra Nikolic, Nedeljko Radlovic,
Amyloidosis in cystic fibrosis: A case series
A.H. Gifford  Journal of Cystic Fibrosis 
Shaoyan Zhang, Neel K. Ranganath, Daniel Skinner, David M
Inhalation solutions — Which ones may be mixed
Wilson disease as a cause of liver injury in cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Optimizing strategies for CFTR molecular testing
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment 
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Cytokine gene polymorphisms and severity of CF lung disease
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene  Marie-Pierre.
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test  Karoline Droebner, Peter Sandner  Journal.
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
B. M. Ciminelli, A. Bonizzato, C. Bombieri, F. Pompei, M. Gabaldo, C
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens  Hongjun.
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Absence of a gender gap in survival
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Wilson disease as a cause of liver injury in cystic fibrosis Radana Kotalová, Milan Jirsa, Věra Vávrová, Slávka Vrábelová-Pouchlá, Milan Macek  Journal of Cystic Fibrosis  Volume 8, Issue 1, Pages 63-65 (January 2009) DOI: 10.1016/j.jcf.2008.09.003 Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Mutations in CFTR, UGT1A1, and ATP7B. Homozygous mutations F508del in CFTR (A) and A(TA)7TAA in the UGT1A1 promoter (B) were found by fragment analysis. The homozygous variant −3279T>C in the UGT1A1 promoter was detected as a PCR-Hpy8I restriction-enzyme fragment length polymorphism (B). The heterozygous mutation c.2930C>T in ATP7B was detected by gene sequencing (C) and as a PCR-NlaIII restriction-enzyme fragment length polymorphism (not shown). WT — wildtype, (TA)7 — A(TA)7TAA. Journal of Cystic Fibrosis 2009 8, 63-65DOI: (10.1016/j.jcf.2008.09.003) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions